Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

252 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Rheumatoid arthritis: Obesity impairs efficacy of anti-TNF therapy in patients with RA.
González-Gay MA, González-Juanatey C. González-Gay MA, et al. Nat Rev Rheumatol. 2012 Nov;8(11):641-2. doi: 10.1038/nrrheum.2012.158. Epub 2012 Sep 25. Nat Rev Rheumatol. 2012. PMID: 23007743 No abstract available.
Rheumatoid arthritis and anti-TNF-alpha therapy.
Gonzalez-Juanatey C, Gonzalez-Gay MA. Gonzalez-Juanatey C, et al. Atherosclerosis. 2005 Jul;181(1):209. doi: 10.1016/j.atherosclerosis.2005.02.031. Atherosclerosis. 2005. PMID: 15899482 No abstract available.
High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis.
Gonzalez-Gay MA, Gonzalez-Juanatey C, Piñeiro A, Garcia-Porrua C, Testa A, Llorca J. Gonzalez-Gay MA, et al. J Rheumatol. 2005 Jul;32(7):1219-23. J Rheumatol. 2005. PMID: 15996055
Effect of anti-tumor necrosis factor alpha therapy on the progression of subclinical atherosclerosis in severe rheumatoid arthritis.
Gonzalez-Juanatey C, Llorca J, Garcia-Porrua C, Martin J, Gonzalez-Gay MA. Gonzalez-Juanatey C, et al. Arthritis Rheum. 2006 Feb 15;55(1):150-3. doi: 10.1002/art.21707. Arthritis Rheum. 2006. PMID: 16463428 Clinical Trial. No abstract available.
Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis.
Gonzalez-Gay MA, De Matias JM, Gonzalez-Juanatey C, Garcia-Porrua C, Sanchez-Andrade A, Martin J, Llorca J. Gonzalez-Gay MA, et al. Clin Exp Rheumatol. 2006 Jan-Feb;24(1):83-6. Clin Exp Rheumatol. 2006. PMID: 16539824
Inflammation and endothelial dysfunction in rheumatoid arthritis.
Gonzalez-Gay MA, Gonzalez-Juanatey C, Martin J. Gonzalez-Gay MA, et al. Clin Exp Rheumatol. 2006 Mar-Apr;24(2):115-7. Clin Exp Rheumatol. 2006. PMID: 16762143 No abstract available.
Short-term adalimumab therapy improves endo-thelial function in patients with rheumatoid arthritis refractory to infliximab.
Gonzalez-Juanatey C, Llorca J, Sanchez-Andrade A, Garcia-Porrua C, Martin J, Gonzalez-Gay MA. Gonzalez-Juanatey C, et al. Clin Exp Rheumatol. 2006 May-Jun;24(3):309-12. Clin Exp Rheumatol. 2006. PMID: 16870100 Clinical Trial.
Influence of anti-TNF-alpha infliximab therapy on adhesion molecules associated with atherogenesis in patients with rheumatoid arthritis.
Gonzalez-Gay MA, Garcia-Unzueta MT, De Matias JM, Gonzalez-Juanatey C, Garcia-Porrua C, Sanchez-Andrade A, Martin J, Llorca J. Gonzalez-Gay MA, et al. Clin Exp Rheumatol. 2006 Jul-Aug;24(4):373-9. Clin Exp Rheumatol. 2006. PMID: 16956426
Cardiovascular disease in rheumatoid arthritis.
Gonzalez-Gay MA, Gonzalez-Juanatey C, Miranda-Filloy JA, Garcia-Porrua C, Llorca J, Martin J. Gonzalez-Gay MA, et al. Biomed Pharmacother. 2006 Dec;60(10):673-7. doi: 10.1016/j.biopha.2006.09.006. Epub 2006 Oct 10. Biomed Pharmacother. 2006. PMID: 17049201 Review.
Anti-TNF-alpha therapy modulates resistin in patients with rheumatoid arthritis.
Gonzalez-Gay MA, Garcia-Unzueta MT, Gonzalez-Juanatey C, Miranda-Filloy JA, Vazquez-Rodriguez TR, De Matias JM, Martin J, Dessein PH, Llorca J. Gonzalez-Gay MA, et al. Clin Exp Rheumatol. 2008 Mar-Apr;26(2):311-6. Clin Exp Rheumatol. 2008. PMID: 18565254 Clinical Trial.
252 results
Jump to page
Feedback